Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

24.00 -0.18 (-0.74%)
Official Closing Price Updated: 7:00 PM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kenvue Inc. Common Stock

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Kenvue (KVUE) Q3 2023 Earnings Call Transcript
KVUE earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Check Out What Whales Are Doing With KVUE
Via Benzinga
Kenvue Reports Healthy Third Quarter 2023 Results
From Kenvue Inc.
Via Business Wire
KENVUE INC. SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Kenvue Inc. (NYSE: KVUE)
From Bernstein Liebhard LLP
Via GlobeNewswire
2 Exceptional Dividend Stocks Near 52-Week Lows. Are They Bargains Now?
Attractive valuation metrics don't always tell the whole story. 
Via The Motley Fool
Peering Into Kenvue's Recent Short Interest
Via Benzinga
Kenvue Inc. (NYSE:KVUE) Shareholder Notice: Lawsuit Alleges Violations of Securities Laws
San Diego, CA -- (SBWIRE) -- 10/24/2023 -- An investor, who purchased shares of Kenvue Inc. (NYSE:KVUE), filed a lawsuit over alleged violations of Federal Securities Laws by Kenvue Inc. in connection... 
Via SBWire
Topics Lawsuit
Exposures Financial Legal
The Best Stocks to Invest $5,000 In Right Now
Today, the following three healthcare players look like fantastic bargains. 
Via The Motley Fool
ROSEN, THE FIRST FILING FIRM, Encourages Kenvue Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm - KVUE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
Down in the Double Digits, These 2 Classic Warren Buffett Stocks Make Great Buys Now
These players could deliver top returns over the long haul. 
Via The Motley Fool
3 Foundational Blue Chip Dow Dividend Stocks for Building Generational Wealth
Dow stocks can provide the confidence needed to hold through periods of volatility. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
KENVUE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Kenvue Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
KVUE Shareholder Update: Johnson Fistel Encourages Kenvue Investors to Seek Counsel Before Lead Plaintiff Class Action Deadline
From Johnson Fistel, LLP
Via Business Wire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Kenvue Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm - KVUE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
These 2 Dow Stocks Moved Markets This Week
Bulls and bears alike looked closely at these two companies. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Kenvue Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm – KVUE
From The Rosen Law Firm PA
Via GlobeNewswire
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Kenvue Inc. (KVUE) Investors and Encourages Investors to Contact the Firm Before December 8, 2023
From Kirby McInerney LLP
Via Business Wire
KVUE Shareholders: Contact Robbins LLP About Your Rights and Remedies in the Kenvue Inc. Securities Fraud Class Action
From Robbins LLP
Via Business Wire
7 Healthcare Stocks That Can Cure a Lackluster Portfolio
Take a position in these companies' stocks to achieve long-term gains and give a jolt to your investment portfolio. 
Via InvestorPlace
Is Johnson & Johnson Still a Good Dividend Stock to Buy?
Investors wonder if the healthcare giant can keep raising its payout now that it no longer sells the consumer health brands that made it famous. 
Via The Motley Fool
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Kenvue Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm - KVUE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
Why Johnson & Johnson Stock Flopped Today
Perhaps those third-quarter results weren't as impressive as they first appeared to be. 
Via The Motley Fool
Is the "New" Johnson & Johnson Stock a Buy With Its Improved Profit Outlook?
Some things are different about J&J. But other things remain the same as they've been for a long time. 
Via The Motley Fool
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kenvue Inc. (KVUE)
From Glancy Prongay & Murray LLP
Via Business Wire
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Kenvue Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm - KVUE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
Johnson & Johnson's Sharper Focus Is Already Paying Dividends for Investors
The healthcare behemoth reported strong earnings after separating its consumer health division. 
Via The Motley Fool
Johnson & Johnson Raises Outlook As The Health Care Bellwether Beats Views
The company beat third-quarter forecasts and raised its outlook for the year. It's now focusing on innovative drugs and medtech following its consumer health spinoff. 
Via Investor's Business Daily
New Johnson & Johnson's Q3 Earnings Beat Street View, Raises Annual Outlook
Johnson & Johnson (NYSE: JNJ) has reported Q3 FY23 adjusted earnings of $2.66 per share, up 19.3% Y/Y and beating the conse 
Via Benzinga
Topics Earnings
Exposures Financial
KENVUE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Kenvue Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kenvue Inc. (KVUE)
From Law Offices of Howard G. Smith
Via Business Wire
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.